Association between inflammatory bowel disease gene 5 (IBD5) and interleukin-23 receptor (IL23R) genetic polymorphisms in Malaysian patients with Crohn's disease

Journal of Digestive Diseases

Volumn 13, Issue 9, 2012, Pages 459-465

  Chua, Kek Heng ^a   Hilmi, Ida ^a   Lian, Lay Hoong ^a   Patmanathan, Sathya Narayanan ^a   Hoe, See Ziau ^a   Lee, Way Seah ^a   Goh, Khean Lee ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Crohn disease; Genetic; IBD5; interleukin 23 receptor; Malaysia; Polymorphism

Indexed keywords

GENOMIC DNA; INFLAMMATORY BOWEL DISEASE GENE 5 PROTEIN; INTERLEUKIN 23 RECEPTOR; PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROHN DISEASE; DNA DETERMINATION; DNA EXTRACTION; GENETIC VARIABILITY; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALAYSIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

CROHN DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALAYSIA; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN;

EID: 84865401615     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2012.00617.x     Document Type: Article

References (34)

1. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-17.
2. Lee YM, Fock K, See SJ, Ng TM, Khor C, Teo EK. Racial differences in the prevalence of ulcerative colitis and Crohn's disease in Singapore. J Gastroenterol Hepatol 2000; 15: 622-5.
3. Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis 2004; 10: 646-51.
4. Colombel JF, Grandbastien B, Gower-Rousseau C etal. Clinical characteristics of Crohn's disease in 72 families. Gastroenterology 1996; 111: 604-7.
5. Peña AS. Genetics of inflammatory bowel diseases - past, present, and future. Dig Dis 2003; 21: 85-90.
6. Chua KH, Hilmi I, Ng CC etal. Identification of NOD2/CARD15 mutations in Malaysian patients with Crohn's disease. J Dig Dis 2009; 10: 124-30.
7. Chua KH, Lian LH, Kee BP etal. Identification of DLG5 and SLC22A5 gene polymorphisms in Malaysian patients with Crohn's disease. J Dig Dis 2011; 12: 459-66.
8. Rioux JD, Daly MJ, Silverberg MS etal. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001; 29: 223-8.
9. Reinhard C, Rioux JD. Role of the IBD5 susceptibility locus in the inflammatory bowel diseases. Inflamm Bowel Dis 2006; 12: 227-38.
10. Duerr RH, Taylor KD, Brant SR etal. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461-3.
11. Parham C, Chirica M, Timans J etal. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002; 168: 5699-708.
12. Murphy CA, Langrish CL, Chen Y etal. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003; 198: 1951-7.
13. Yanagida T, Kato T, Igarashi O, Inoue T, Nariuchi H. Second signal activity of IL-12 on the proliferation and IL-2R expression of T helper cell-1 clone. J Immunol 1994; 152: 4919-28.
14. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007; 117: 514-21.
15. Yamazaki K, Onouchi Y, Takazoe M, Kubo M, Nakamura Y, Hata A. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients. J Hum Genet 2007; 52: 575-83.
16. Glas J, Seiderer J, Wetzke M etal. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PloS One 2007; 2: e819.
17. Chua KH, Kee BP, Tan SY, Lian LH. Interleukin-6 promoter polymorphisms (-174 G/C) in Malaysian patients with systemic lupus erythematosus. Braz J Med Biol Res 2009; 42: 551-5.
18. Chua KH, Puah SM, Chew CH, Tan SY, Lian LH. Study of the CTLA-4 gene polymorphisms in systemic lupus erythematosus (SLE) samples from Malaysia. Ann Hum Biol 2010; 37: 274-80.
19. Chua KH, Lau TP, Tee ZY, Tan SY, Lian LH. Genetic polymorphisms of the interleukin-1 beta (IL-1β) -511 and +3954 single nucleotide polymorphisms (SNPs) in the Malaysian systemic lupus erythematosus (SLE) patients. J Health Sci 2009; 55: 657-62.
20. Csöngei V, Járomi L, Sáfrány E etal. Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients. World J Gastroenterol 2010; 16: 176-83.
21. Teh CS, Chua KH, Thong KL. Simultaneous differential detection of human pathogenic and non-pathogenic Vibrio species using a multiplex PCR based on gyrB and pntA genes. J Appl Microbiol 2010; 108: 1940-5.
22. Thong KL, Lai MY, Teh C SJ, Chua KH. Simultaneous detection of methicillin-resistant Staphylococcus aureus, Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa by multiplex PCR. Trop Biomed 2011; 28: 21-31.
23. Puah SM, Lian LH, Chew CH, Chua KH, Tan SY. A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population. Lupus 2007; 16: 750-4.
24. Dawson B, Trapp RG. Basic and Clinical Biostatistics, 4th edn. New York: Mc-Graw-Hill 2004.
25. Silverberg MS, Duerr RH, Brant SR etal; NIDDK IBD Genetics Consortium. Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease. Eur J Hum Genet 2007; 15: 328-35.
26. Lakner L, Csöngei V, Sarlós P etal. IGR2096a_1 T and IGR2198a_1 C alleles on IBD5 locus of chromosome 5q31 region confer risk for Crohn's disease in Hungarian patients. Int J Colorectal Dis 2009; 24: 503-7.
27. Törkvist L, Noble CL, Lördal M etal. Contribution of the IBD5 locus to Crohn's disease in the Swedish population. Scand J Gastroenterol 2007; 42: 200-6.
28. Palmieri O, Latiano A, Valvano R etal. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 2006; 23: 497-506.
29. Russell RK, Drummond HE, Nimmo ER etal. Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease. Gut 2006; 55: 1114-23.
30. National Centre of Biotechnology Information (NCBI). Reference assembly. Cited: 7 June 2012. Available from URL: http://www.ncbi.nlm.nih.gov.
31. Hilmi I, Tan YM, Goh KL. Crohn's disease in adults: observations and a multiracial Asian population. World J Gastroenterol 2006; 12: 1435-8.
32. Einarsdottir E, Koskinen LL, Dukes E etal. IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. BMC Med Genet 2009; 10: 8.
33. Baptista ML, Amarante H, Picheth G etal. CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population. Inflamm Bowel Dis 2008; 14: 674-9.
34. Mannon PJ, Fuss IJ, Mayer L etal.; Anti-IL-12 Crohn's Disease Study Group. Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med 2004; 351: 2069-79.